Session Information
2013 Summer Meeting
Click here to go to the previous page
340B UniversityTM
Track:
Pre-Meeting Workshops (CE)
Date: Saturday, June 1, 2013
Time: 7:45 AM to 5:15 PM EST
Location:
200 C, Level 2
PROGRAM CHAIR:
Mr. Christopher Hatwig, M.S., R.Ph., President, 340B Prime Vendor Program, Apexus
Description
Note: The deadline to register for this workshop is May 1st.
Offered by Apexus, the awarded contractor to manage the 340B Prime Vendor Program for the Health Resources and Services Administration’s Office of Pharmacy Affairs.
Apexus is offering a comprehensive review of the 340B Drug Pricing Program. The goal of the program is to provide an understanding of the 340B drug pricing program, its development, implementation and policies surrounding its utilization.
340B University™ will provide you with many opportunities for hands-on, practical advice to help with program implementation, including: learning innovative strategies to reduce costs, remaining compliant and improving care. There will be opportunities to participate in small breakout sessions, to get the advice from industry leaders, and to network with peers!
ACPE Credit: ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Statements of credit can be received online at the conclusion of the workshop. Participants must complete an online program evaluation in order to receive pharmacy CE credit. No partial credit will be given.
Faculty:
Rose Babbitt, RPh, Vice President, Federal Contracts and Grants, HRSA Contractor
John Barnes, CPM, Senior Director, Contract Services, Apexus
Patrick Barnes, RPh, Team Leader, Drug Control, Shands Jacksonville,
BJ Centers, Senior Director, Operations and Analytics, Apexus
Marcus Farbstein, Director, 340B Program, Genentech
Christopher Hatwig, MS, RPh, FASHP, President, Apexus
Todd Karpinski, PharmD, MS, Executive Director of Pharmacy, Froedtert Hospital
Perry Knight, JD, Senior Counsel, Johnson and Johnson
Robert Nahoopii, PharmD, MS, Director of Pharmacy, Utah Valley Regional Medical Center
Krista Pedley, PharmD, MS, Director, HRSA Office of Pharmacy Affairs (via web)
Katheryne Richardson, PharmD, Senior Director Policy, Apexus
Andrew L. Wilson, PharmD, FASHP, Vice President, 340B Solutions, McKesson
Amy VanDeCar, Vice President, Government Programs, CIS
Offered by Apexus, the awarded contractor to manage the 340B Prime Vendor Program for the Health Resources and Services Administration’s Office of Pharmacy Affairs.
Apexus is offering a comprehensive review of the 340B Drug Pricing Program. The goal of the program is to provide an understanding of the 340B drug pricing program, its development, implementation and policies surrounding its utilization.
340B University™ will provide you with many opportunities for hands-on, practical advice to help with program implementation, including: learning innovative strategies to reduce costs, remaining compliant and improving care. There will be opportunities to participate in small breakout sessions, to get the advice from industry leaders, and to network with peers!
ACPE Credit: ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Statements of credit can be received online at the conclusion of the workshop. Participants must complete an online program evaluation in order to receive pharmacy CE credit. No partial credit will be given.
Faculty:
Rose Babbitt, RPh, Vice President, Federal Contracts and Grants, HRSA Contractor
John Barnes, CPM, Senior Director, Contract Services, Apexus
Patrick Barnes, RPh, Team Leader, Drug Control, Shands Jacksonville,
BJ Centers, Senior Director, Operations and Analytics, Apexus
Marcus Farbstein, Director, 340B Program, Genentech
Christopher Hatwig, MS, RPh, FASHP, President, Apexus
Todd Karpinski, PharmD, MS, Executive Director of Pharmacy, Froedtert Hospital
Perry Knight, JD, Senior Counsel, Johnson and Johnson
Robert Nahoopii, PharmD, MS, Director of Pharmacy, Utah Valley Regional Medical Center
Krista Pedley, PharmD, MS, Director, HRSA Office of Pharmacy Affairs (via web)
Katheryne Richardson, PharmD, Senior Director Policy, Apexus
Andrew L. Wilson, PharmD, FASHP, Vice President, 340B Solutions, McKesson
Amy VanDeCar, Vice President, Government Programs, CIS
- Describe the history, intent, and statutory principals of the 340B program.
- Describe the role of the manufacturer, wholesaler, prime vendor and entity in 340B pricing integrity.
- List methods to optimize the value of 340B Prime Vendor Program Services.
- Outline the process for addressing 340B policy and the maintenance of integrity of the 340B Program participation.
| No items are available for this session. |